TG Therapeutics | TGTX - 销售毛利



金融业
股票价格
USD
资产
USD 1.64B
现金及等价物
USD 612.25M
销售成本
USD 41.19M
流动资产
USD 1.15B
流动负债
USD 268.49M
债务
USD 754.44M
EBIT
USD 21.67M
EBITDA
USD 26.9M
员工
338
EPS每股收益
USD 0.05
股本和储备
USD 604.08M
销售毛利
USD 199.14M
债务利息支出
USD 16.57M
贷款资金
USD 745.39M
市值
USD 8.74B
净收入
USD 7.78M
营业费用
USD 218.66M
营业利润
USD 21.67M
普通股股本
USD 153.08M
PE价格收益
19.64
税前利润
USD 10.23M
销售收入
USD 240.34M
销售和管理费用
USD 62.33M
股票
USD 147.97M
贸易债权人
USD 213.69M
应收帐款人
USD 401.57M


销售毛利 更改 日
AbbVie USD 14.39B 1.85B 2026-06
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 5.87B 1.02B 2026-03
Ardelyx USD 89.66M 24.7M 2026-03
Arrowhead Research USD 75.25M 1.52M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Biogen USD 2.12B 307M 2026-06
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Curis USD 1.14M 8.86M 2025-12
Gilead Sciences USD 6.8B 1.29B 2026-06
J&J USD 18.55B 1.31B 2026-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Novavax USD 125.04M 76.09M 2025-12
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
TG Therapeutics USD 199.14M 27.73M 2026-06
Verastem USD 15.62M 977K 2026-03
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06